CL2011001775A1 - Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble. - Google Patents

Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble.

Info

Publication number
CL2011001775A1
CL2011001775A1 CL2011001775A CL2011001775A CL2011001775A1 CL 2011001775 A1 CL2011001775 A1 CL 2011001775A1 CL 2011001775 A CL2011001775 A CL 2011001775A CL 2011001775 A CL2011001775 A CL 2011001775A CL 2011001775 A1 CL2011001775 A1 CL 2011001775A1
Authority
CL
Chile
Prior art keywords
vitamin
antiparasitary
benzyl benzoate
doramectin
preservatives
Prior art date
Application number
CL2011001775A
Other languages
English (en)
Inventor
Stephen Lee Secreast
Alvimar Jose Costa
Rodrigo Valarelli
Original Assignee
Zoetis Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zoetis Llc filed Critical Zoetis Llc
Publication of CL2011001775A1 publication Critical patent/CL2011001775A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042—Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048—Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/07—Retinol compounds, e.g. vitamin A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A61K31/355—Tocopherols, e.g. vitamin E
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00—Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04—Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08—Hetero rings containing eight or more ring members, e.g. erythromycins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

COMPOSICIÓN VETERINARIA ANTIPARASITARIA QUE COMPRENDE DORAMECTINA, ACEITE DE ALGODÓN. BENZOATO DE BENCILO; COMPOSICIÓN VETERINARIA POLIETÁPICA ANTIPARASITARIA QUE COMPRENDE DORAMECTINA, AGENTE ANTIPARASITARIO O COMBINACIÓN DE MÁS DE UN AGENTE ANTIPARASITARIO SELECCIONADO DEL GRUPO QUE CONSISTE EN ABAMECTINA, IVERMECTINA, EPRINOMECTINA. MOXIDECTINA Y MILBEMICINA , OTROS COMPONENTES OPCIONALES ENTRE UN CONSERVANTE. EXCIPIENTE AUXILIAR Y VITAMINA LIPOSOLUBLE. EN LA QUE DICHA VITAMINA SE SELECCIONA DEL GRUPO QUE CONSISTE EN VITAMINA A, VITAMINA O Y VITAMINA E. LAS COMPOSICIONES DAN A CONOCER UNA EFICACIA ANTIPARASITARIA Y UN TIEMPO DE RETENCIÓN SIGNIFICATIVAMENTE REDUCIDO.<br />  
CL2011001775A 2009-02-16 2011-07-21 Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble. CL2011001775A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US15291109P 2009-02-16 2009-02-16
US21983709P 2009-06-24 2009-06-24

Publications (1)

Publication Number Publication Date
CL2011001775A1 true CL2011001775A1 (es) 2011-10-28

Family

ID=42060687

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2011001775A CL2011001775A1 (es) 2009-02-16 2011-07-21 Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble.

Country Status (20)

Country Link
US (1) US8551962B2 (es)
EP (1) EP2396006B1 (es)
JP (1) JP2012517994A (es)
KR (1) KR101326428B1 (es)
CN (1) CN102316876B (es)
AR (1) AR075428A1 (es)
AU (1) AU2010233409B2 (es)
BR (1) BRPI1008822B1 (es)
CA (1) CA2750626C (es)
CL (1) CL2011001775A1 (es)
CO (1) CO6410307A2 (es)
DK (1) DK2396006T3 (es)
ES (1) ES2399228T3 (es)
HK (1) HK1161087A1 (es)
MX (1) MX2011008614A (es)
NZ (1) NZ594389A (es)
PL (1) PL2396006T3 (es)
PT (1) PT2396006E (es)
WO (1) WO2010116267A1 (es)
ZA (1) ZA201105310B (es)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9616044B2 (en) 2012-03-13 2017-04-11 Bayer New Zealand Ltd Long acting compositions
ES2436249B1 (es) * 2012-06-25 2014-06-23 Javier Alberto ALONSO-VAQUERO VELASCO Composición antiparasitaria para el control y tratamiento de parásitos de diferentes especies animales, caracterizada por combinar Moxidectina con las vitaminas: A, D3, y E
WO2014098623A1 (en) * 2012-12-20 2014-06-26 Alleva Animal Health Limited Injectable eprinomectin formulation and anthelmintic use thereof
CN103977017B (zh) * 2014-06-03 2016-09-07 重庆布尔动物药业有限公司 一种兽用抗寄生虫注射液及其制备方法

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES8800986A1 (es) 1985-07-27 1987-12-01 Pfizer Un procedimiento para la produccion de un nuevo derivado de avermectina
US6001822A (en) 1989-04-11 1999-12-14 Pfizer Inc. Antiparasitic formulations
ES2052173T3 (es) 1989-04-11 1994-07-01 Pfizer Composiciones inyectables que contienen 25-cyclohexil-avermectina b1.
WO1997011709A1 (en) * 1995-09-25 1997-04-03 Ashmont Holdings Limited Anthelmintic macrocyclic lactone compositions
DE19613972A1 (de) 1996-04-09 1997-10-16 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen auf Basis von Rizinusöl
AU728221B2 (en) 1996-06-05 2001-01-04 Ashmont Holdings Limited Injectable compositions
DE19638045A1 (de) * 1996-09-18 1998-03-19 Bayer Ag Injektionsformulierungen von Avermectinen und Milbemycinen
US6174540B1 (en) 1998-09-14 2001-01-16 Merck & Co., Inc. Long acting injectable formulations containing hydrogenated caster oil
KR20000025762A (ko) * 1998-10-14 2000-05-06 유충식 이버멕틴류의 가용화 조성물
GB9825402D0 (en) * 1998-11-19 1999-01-13 Pfizer Ltd Antiparasitic formulations
GB9827727D0 (en) 1998-12-16 1999-02-10 Pfizer Ltd Antiparasitic formulations
CN1304727A (zh) * 2000-10-20 2001-07-25 王玉万 一种以苯甲酸苄酯或氮酮为助溶剂的含阿维菌素或伊维菌素的注射液

Also Published As

Publication number Publication date
EP2396006A1 (en) 2011-12-21
NZ594389A (en) 2012-09-28
ES2399228T3 (es) 2013-03-26
US20110294751A1 (en) 2011-12-01
PL2396006T3 (pl) 2013-06-28
KR20110116231A (ko) 2011-10-25
CA2750626A1 (en) 2010-10-14
US8551962B2 (en) 2013-10-08
HK1161087A1 (en) 2012-08-24
AR075428A1 (es) 2011-03-30
BRPI1008822B1 (pt) 2019-04-09
CN102316876B (zh) 2013-07-17
CO6410307A2 (es) 2012-03-30
DK2396006T3 (da) 2013-02-11
WO2010116267A1 (en) 2010-10-14
PT2396006E (pt) 2013-02-13
CA2750626C (en) 2013-10-01
AU2010233409B2 (en) 2012-05-17
AU2010233409A1 (en) 2011-08-11
EP2396006B1 (en) 2012-12-19
CN102316876A (zh) 2012-01-11
JP2012517994A (ja) 2012-08-09
KR101326428B1 (ko) 2013-11-20
ZA201105310B (en) 2012-09-26
MX2011008614A (es) 2011-09-09
BRPI1008822A2 (pt) 2016-03-08

Similar Documents

Publication Publication Date Title
UY37952A (es) Formulaciones de un inhibidor de la quinasa trk macrocíclica
DOP2018000085A (es) Composiciones veterinarias orales parasiticidas que comprenden agentes activos de actuación sistémica y sus usos
CO6341526A2 (es) Povidona yodada, un preservativo alternativo novedoso para composiciones oftalmologicas
CU20190005A7 (es) Goma de mascar administrable oralmente o formulaciones acuosas que comprenden un agente farmacéutico
CL2015001449A1 (es) Composición que comprende un agente de control biológico y un insecticida
CL2017000955A1 (es) Composición que comprende un agente de control biológico de la especie bacillus subtilis y un fungicida del grupo de inhibidores de la mitosis y la división celular, tal como clorotalonilo
CL2012003684A1 (es) Una solucion oftalmica que incluye por lo menos una prostaglandina, un agente solubilizador, un agente gelificador carbomero, un agente inhibidor de la polimerizacion del carbomero y un agente co-gelificador/co-solubilizador, la cual tiene una viscosidad entre 8 y 20 mpa.s y no contiene conservadores antimicrobianos; y frasco que la comprende.
CL2010000234A1 (es) Combinacion fungicida que comprende fluoxaestrobin y al menos un imidazol seleccionado entre cyzofamid, prochloraz, triazoxide o pefurazoate y usos de la misma para combatir hongos fitopatogenos y en la obtencion de composiciones fungicidas que comprenden ademas agentes extendedores y/o surfactantes (divisional de 2673-2005)
AR069552A1 (es) Formulaciones para el tratamiento de semillas y metodos de uso
CL2011000346A1 (es) Uso de al menos un estabilizador seleccionado del grupo que consiste en aceite animal y/o vegetal epoxidado, un agente tensoactivo no ionico de polioxietileno, un agente tensoactivo anionico de polioxietileno, un alcohol polihidrico y una sustancia basica; para controlar la degradacion de ciazofamida.
CR7140A (es) Antranilamidas con una cadena colateral de un heteroarylsulfonil, metodos para la produccion de los mismos, su uso como medicamento o agente diagnostico y preparaciones farmaceuticas contenidas en dichos compuestos
CR20120140A (es) Composiciones de liberación controlada
ECSP045320A (es) Composición parasitaria de larga duración
AR056500A1 (es) Metodo para preparar una composicion medica
CO6280437A2 (es) Una composicion de emulsion de aceite en agua que tiene una fase de agua y nua fase de aceite comprendiendo un modificador polimerico y un compuesto activo agricolamente
AR077372A1 (es) Composiciones y metodos para tratar infecciones oftalmicas oticas o nasales
CL2011001775A1 (es) Composicion veterinaria antiparasitaria que comprende doramectina, aceite de algodon, benzoato de bencilo y uno o mas entre conservantes, excipientes y vitamina liposoluble.
DOP2016000007A (es) Pirazolpiridinas sustituidas
AR094874A1 (es) Formulaciones para el tratamiento de semillas
CR20110190A (es) Agente rodenticida sinérgico
CL2012002893A1 (es) Composición de al menos un ingrediente activo de origen vegetal o sintético análogo del mismo, o extracto de origen vegetal que lo contiene, en una solución acuosa, que además comprende lecitina como agente encapsulante; medicamento que la comprende; método para su preparación; y su uso para tratar parasitosis intestinales.
AR091739A1 (es) Composiciones y metodos para reducir el riesgo cardiometabolico
AR073057A1 (es) Combinaciones insecticidas de abamectina y ciflumetofeno y composiciones que las comprenden.
BR112015013689A2 (pt) composições fluidas de cuidado oral contendo peróxido
MX2017012276A (es) Composiciones de peroxido organicas coloreadas.